EKF Diagnostics buys back 200,000 shares at 25.125p average

PENARTH, Wales - EKF Diagnostics Holdings plc (AIM:EKF) acquired 200,000 of its own ordinary shares on Sunday, August 17, at a volume weighted average price of 25.125 pence per share, according to a company press release. The diagnostics firm purchased the shares within a price range of 25.000p to 25.500p throughout the trading day on the AIM exchange.

The total value of the transactions amounted to 5,025,000 pence. The shares bought will subsequently be canceled, reducing EKF’s total issued share capital from 428,688,112 ordinary shares of 1p each to 428,688,112 ordinary shares. Notably, EKF Diagnostics holds no shares in treasury. The company is a global leader in point-of-care analyzers for hematology and diabetes, operating five manufacturing sites in the United States and Germany, and serving over 120 countries.